Comparison of different routes of vaccination for eliciting antibody responses in the human stomach

Vaccine

Volumn 22, Issue 8, 2004, Pages 984-990

  Johansson, Eva Liz ^a   Bergquist, Charlotta ^a   Edebo, Anders ^a   Johansson, Camilla ^a   Svennerholm, Ann Mari ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Antibody responses in stomach; Helicobacter pylori vaccination; Human

Indexed keywords

ANTIBODY; CHOLERA VACCINE; IMMUNOGLOBULIN A; INACTIVATED VACCINE; SAPONIN;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DUODENUM; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; HELICOBACTER INFECTION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION PREVENTION; INTERMETHOD COMPARISON; MUCOSAL IMMUNITY; PRIORITY JOURNAL; STOMACH ANTRUM; STOMACH BIOPSY;

EID: 1242270646     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.09.002     Document Type: Article

References (27)

1. Genta R.M., Gurer I.E., Graham D.Y. Geographical pathology of Helicobacter pylori infection: is there more than one gastritis? Ann. Med. 27:1995;595-599.
2. Parsonnet J., Hansen S., Rodriguez L., Gelb A.B., Warnke R.A., Jellum E.et al. Helicobacter pylori infection and gastric lymphoma. N. Engl. J. Med. 330:1994;1267-1271. [see comments].
3. Peek R.M. Jr., Blaser M.J. Pathophysiology of Helicobacter pylori-induced gastritis and peptic ulcer disease. Am. J. Med. 102:1997;200-207.
4. Bogstedt A.K., Nava S., Wadstrom T., Hammarstrom L. Helicobacter pylori infections in IgA deficiency: lack of role for the secretory immune system. Clin. Exp. Immunol. 105:1996;202-204.
5. Czinn S.J., Cai A., Nedrud J.G. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine. 11:1993;637-642.
6. Lee C.K., Weltzin R., Thomas W.D. Jr., Kleanthous H., Ermak T.H., Soman G.et al. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J. Infect. Dis. 172:1995;161-172.
7. Pappo J., Thomas W.D. Jr., Kabok Z., Taylor N.S., Murphy J.C., Fox J.G. Effect of oral immunization with recombinant urease on murine Helicobacter felis gastritis. Infect. Immun. 63:1995;1246-1252.
8. Sutton P., Wilson J., Kosaka T., Wolowczuk I., Lee A. Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies. Immunol. Cell Biol. 78:2000;28-30.
9. Thomas J.E., Austin S., Dale A., McClean P., Harding M., Coward W.A.et al. Protection by human milk IgA against Helicobacter pylori infection in infancy. Lancet. 342:1993;121. [letter].
10. Bergquist C., Johansson E.-L., Lagergard T., Holmgren J., Rudin A. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect. Immun. 65:1997;2676-2684.
11. Holmgren J. Actions of cholera toxin and the prevention and treatment of cholera. Nature. 292:1981;413-417.
12. Holmgren J., Svennerholm A.-M. Bacterial enteric infections and vaccine development. Gastroenterol. Clin. North Am. 21:1992;283-302.
13. Mattsson A., Lönroth H., Quiding-Jarbrink M., Svennerholm A.-M. Induction of B cell responses in the stomach of Helicobacter pylori-infected subjects after oral cholera vaccination. J. Clin. Invest. 102:1998;51-56.
14. Quiding-Jarbrink M., Lönroth H., Ahlstedt I., Holmgren J., Svennerholm A.-M. Human gastric B cell responses can be induced by intestinal immunisation. Gut. 49:2001;512-518.
15. Johansson E.-L., Rask C., Fredriksson M., Eriksson K., Czerkinsky C., Holmgren J. Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates. Infect. Immun. 66:1998;514-520.
16. Russell M.W., Moldoveanu Z., White P.L., Sibert G.J., Mestecky J., Michalek S.M. Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the cholera toxin B subunit. Infect. Immun. 64:1996;1272-1283.
17. Rudin A., Johansson E.-L., Bergquist C., Holmgren J. Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of humans. Infect. Immun. 66:1998;3390-3396.
18. Corthesy-Theulaz I.E., Hopkins S., Bachmann D., Saldinger P.F., Porta N., Haas R.et al. Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits. Infect. Immun. 66:1998;581-586.
19. Kleanthous H., Myers G.A., Georgakopoulos K.M., Tibbitts T.J., Ingrassia J.W., Gray H.L.et al. Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection. Infect. Immun. 66:1998;2879-2886.
20. Sanchez J., Holmgren J. Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholera as a basis for vaccine development. Proc. Natl. Acad. Sci. U.S.A. 86:1989;481-485.
21. Bergquist C., Mattsson-Rydberg A., Lönroth H., Svennerholm A.-M. Development of a new method for the determination of immune responses in the humans stomach. J. Immunol. Methods. 234:2000;51-59.
22. Jertborn M., Svennerholm A.-M., Holmgren J. Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease. J. Clin. Microbiol. 24:1986;203-209.
23. Owen D.A. Normal histology of the stomach. Am. J. Surg. Pathol. 10:1986;48-61.
24. Stolte M., Eidt S. Lymphoid follicles in antral mucosa: immune response to Campylobacter pylori? J. Clin. Pathol. 42:1989;1269-1271.
25. Wyatt J.I., Rathbone B.J. Immune response of the gastric mucosa to Campylobacter pylori. Scand. J. Gastroenterol. Suppl. 142:1988;44-49.
26. Svennerholm A-M, Sack DA, Holmgren J, Bardhan PK. Intestinal antibody responses after immunisation with cholera B subunit. Lancet 1982;305-8.
27. Svennerholm A.-M., Jertborn M., Gothefors L., Karim A.M., Sack D.A., Holmgren J. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine. J. Infect. Dis. 149:1984;884-893.